CAS 834153-87-6

General Information

Elagolix, sold under the brand name Orilissa, is the first oral gonadotropin-releasing hormone antagonist used to treat endometriosis.

At Teva api, we offer an amorphous form of the API and have successfully stabilized it, thereby addressing its hygroscopocity.

Samples are available for development, as well as DMFs for all your regulatory needs. Talk to us today!

About the API

Systematic name N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide
Trade name(s) amorphous
Technology Synthetic
Therapeutic category Genitourinary
Available formulations Oral Solid
Regulations US DMF Flag US DMF